Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%), etc.
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RAPPAPORT ANDREW
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Paradigm BioCapital Advisors LP(14.3%),Paradigm BioCapital Advisors GP LLC(14.3%), etc.
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(4.49%),Bihua Chen(4.49%), etc.
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(0%),Kynam Capital Management GP, LLC(0%), etc.
Olema Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(1.3%)
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bohen Sean
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kovacs Shane William Charles
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Myles David C.
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
Olema Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zojwalla Naseem
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kovacs Shane William Charles
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Harmon Cyrus
No Data